Related Experiment Videos
Measuring tumor blood flow with H(2)(15)O: practical considerations
S L Bacharach1, S K Libutti, J A Carrasquillo
1NIH/Clinical Center, Bethesda, Maryland 20892-1180, USA.
Nuclear Medicine and Biology
|November 25, 2000
Summary
Measuring tumor blood flow non-invasively is crucial for therapy monitoring and drug delivery assessment. Labeled water-H(2)(15)O offers a highly applicable radiotracer method due to its diffusion and modeling properties.
Area of Science:
- Oncology
- Radiochemistry
- Medical Imaging
Background:
- Non-invasive measurement of tumor blood flow is vital for cancer research.
- Assessing tumor physiology, drug delivery, and therapy response requires accurate blood flow quantification.
Purpose of the Study:
- To analyze the bolus injection water methodology for monitoring tumor blood flow.
- To discuss different formulations of this method and potential challenges in its application to tumors.
Main Methods:
- Utilizing labeled water-H(2)(15)O as a radiotracer.
- Analyzing bolus injection techniques adapted from cardiac and cerebral blood flow studies.
- Modeling tracer uptake and clearance dynamics.
Main Results:
- Labeled water-H(2)(15)O is highly diffusible and minimally metabolized, making it suitable for tumor studies.
- The methodology allows for the modeling of tracer kinetics for blood flow assessment.
- Adaptation of existing methodologies presents specific challenges for tumor applications.
Conclusions:
- The labeled water-H(2)(15)O bolus injection method shows significant promise for non-invasive tumor blood flow measurement.
- Further analysis and adaptation are needed to overcome challenges in applying this technique to tumors.
- This method could enhance tumor therapy monitoring and drug delivery assessment.